- Supported exchanges /
- F /
- 5Y6.F
COMPASS PATHW SP.ADR (5Y6 F) stock market data APIs
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
COMPASS PATHW SP.ADR Financial Data Overview
5.6 | |
5.7 | |
- | |
5.7 | |
5.5 | |
4.84-11.7 | |
394 M | |
68 388 K | |
0 | |
2.262 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
COMPASS PATHW SP.ADR Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -141 304 992
- Earnings Per Share -2.07
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get COMPASS PATHW SP.ADR Earnings via APIs
- Latest Release 2024-10-31
- EPS/Forecast NaN
Get COMPASS PATHW SP.ADR End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: